+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1



Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1



Genes and Development 7(12a): 2308-2317



The transforming growth factors beta (TGFs-beta) are potent inhibitors of cell proliferation and are usually secreted in a latent form. TGF-beta 1, TGF-beta 2, and TGF-beta 3 are expressed in distinct but overlapping patterns in the developing mouse mammary gland. To study the role of transforming growth factor-beta 1 (TGF-beta 1) in normal mammary development and in mammary neoplasia, we have constructed three transgenic mouse lines that express a simian TGF-beta 1 s223/225 mutated to produce a constitutively active product under the control of the MMTV enhancer/promoter. Expression of the transgene, as confirmed by in situ hybridization, immunohistochemistry, and Northern blot analysis, was associated with marked suppression of the normal pattern of mammary ductal tree development in female transgenics. Reduction in total ductal tree volume was observed at 7 weeks, soon after estrous begins, and was most apparent at 13 weeks, as ductal growth in the normal mammary gland declines. This effect was seen in all three lines. However, during pregnancy, alveolar outgrowths developed from the hypoplastic ductal tree, and lactation occurred, therefore, all transgenic females could feed full litters. Unlike many other transgenic mouse models in which expression of growth factors or oncogenes under control of the MMTV promoter leads to mammary epithelial hyperplasia and increased tumor formation, the MMTV-TGF-beta 1S223/225 transgene causes conditional hypoplasia of the mammary ductal tree and no spontaneous tumors have been detected in the MMTV-TGF-beta 1S223/225 transgenic animals.

(PDF emailed within 0-6 h: $19.90)

Accession: 046411767

Download citation: RISBibTeXText

PMID: 8253379

DOI: 10.1101/gad.7.12a.2308


Related references

Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. American Journal of Pathology 163(4): 1539-1549, 2003

Mammary gland development in transgenic mice expressing a dominant-negative transforming growth factor-beta type II receptor under the control of the mouse mammary tumor virus promoter/enhancer. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 188, 1995

Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland. Transgenic Research 14(5): 719-727, 2005

Mammary development and milk secretion in transgenic mice expressing the sheep beta-lactoglobulin gene. Biochemical Journal 284: 717-720, 1992

Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands. Carcinogenesis (Oxford) 28(6): 1356-1363, 2007

Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands. Carcinogenesis 28(6): 1356-1363, 2006

Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Molecular Biology of the Cell 6(10): 1287-1303, 1995

6-Methyl-8-beta-ergoline-acetonitrile-induced inhibition of mammary hyperplastic alveolar nodular development and growth in C3H-HeJ female mice. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 142(4): 1067-1071, 1973

Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Molecular Endocrinology 11(12): 1766-1781, 1997

Formation of duct-alveolar structures and new types of tumors by a pregnancy-dependent mouse mammary tumor (TPDMT-4) in virgin mice. Gan 73(3): 372-376, 1982

Mammary gland tumor in transgenic mice expressing targeted beta-casein/HPV16E6 fusion gene. International Journal of Oncology 17(6): 1093-1098, 2000

Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant. Hormones and Cancer 3(5-6): 227-239, 2013

Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology. Annals of the New York Academy of Sciences 695: 224-227, 1993

Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 143(10): 4074-4083, 2002